Neuroone Medical Technologies (NMTC) Equity Average (2016 - 2025)
Neuroone Medical Technologies (NMTC) has disclosed Equity Average for 12 consecutive years, with $6.7 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Equity Average rose 258.62% year-over-year to $6.7 million, compared with a TTM value of $6.7 million through Dec 2025, up 258.62%, and an annual FY2025 reading of $3.9 million, up 11.64% over the prior year.
- Equity Average was $6.7 million for Q4 2025 at Neuroone Medical Technologies, down from $7.6 million in the prior quarter.
- Across five years, Equity Average topped out at $14.5 million in Q1 2022 and bottomed at $1.9 million in Q4 2024.
- Average Equity Average over 5 years is $6.7 million, with a median of $6.4 million recorded in 2021.
- The sharpest move saw Equity Average surged 1161.06% in 2021, then crashed 64.78% in 2024.
- Year by year, Equity Average stood at $11.3 million in 2021, then fell by 21.0% to $8.9 million in 2022, then crashed by 39.99% to $5.3 million in 2023, then tumbled by 64.78% to $1.9 million in 2024, then skyrocketed by 258.62% to $6.7 million in 2025.
- Business Quant data shows Equity Average for NMTC at $6.7 million in Q4 2025, $7.6 million in Q3 2025, and $4.7 million in Q2 2025.